Eicosanoid excretion in hepatic cirrhosis. Predominance of 20-HETE

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1264-1270

  Sacerdoti, David ^a   Balazy, Michael ^b   Angeli, Paolo ^a   Gatta, Angelo ^a   McGiff, John C ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

16 ,17 ,18 HETEs; Arachidonate metabolites; Cytochrome P450; Hepatorenal syndrome; Renal eicosanoids; Thromboxane

Indexed keywords

HYDROXYICOSATETRAENOIC ACID; ICOSANOID; PROSTAGLANDIN DERIVATIVE; THROMBOXANE;

ADULT; ARTICLE; ASCITES; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; ICOSANOID METABOLISM; KIDNEY PLASMA FLOW; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030924008     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119640     Document Type: Article

References (49)

1. Epstein, M. 1988. Renal sodium handling in liver disease. In The Kidney in Liver Disease. M. Epstein, editor. Williams & Wilkins, Baltimore, MD. 3-30.
2. Epstein, M., D.P. Berk, N.K. Hollenberg, D.F. Adams, T.C. Chalmers, H.L. Abrams, and J.P. Merrill. 1970. Renal failure in patients with cirrhosis: the role of active vasoconstriction. Am. J. Med. 49:175-185.
3. Arroyo, V., R. Planas, J. Gaya, R. Deulofeu, A. Rimola, R.M. Perez-Ayuso, F. Rivera, and J. Rodes. 1983. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis:relationship to functional renal failure and sodium and water excretion. Eur. J. Clin. Invest. 13:271-278.
4. Sacerdoti, D., M. Bolognesi, C. Merkel, P. Angeli, and A. Gatta. 1993. Renal vasoconstriction in cirrhosis evaluated by duplex Doppler ultrasonography. Hepatalogy. 17:219-224.
5. Kew, M.C., R.R. Varma, H.S. Williams, P.W. Brunt, K.J. Hourigan, and S. Sherlock. 1971. Renal and intrarenal blood flow in cirrhosis of the liver. Lancet. 2:504-509.
6. Sacerdoti, D., A. Merlo, C. Merkel, R. Zuin, and A. Gatta. 1986. Redistribution of renal blood flow in patients with liver cirrhosis. The role of renal PGE2. J. Hepatol. 2:253-261.
7. Naccarato, R., P. Messa, A. D'Angelo, A. Fabris, M. Messa, M. Chiaramonte, C. Gregolin, and G. Zanon. 1981. Renal handling of sodium and water in early chronic liver disease. Gastroenterology. 81:205-210.
8. Angeli, P., A. Gatta, L. Caregaro, F. Menon, D. Sacerdoti, C. Merkel, M. Rondana, R. De Toni, and A. Ruol. 1990. Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. Eur. J. Clin. Invest. 20:111-117.
9. Ring-Larsen, H., B. Hesse, J.H. Henriksen, and N.J. Christensen. 1982. Sympathetic nervous activity and renal and systemic hemodynamics in cirrhosis: plasma norepinephrine concentration, hepatic extraction and renal release. Hepatology. 2:304-310.
10. Bichet, D., V. Szatalowicz, C. Chaimovitz, and R.W. Schrier. 1982. Role of vasopressin in abnormal water excretion in cirrhotic patients. Ann. Intern. Med. 96:413-417.
11. Rimola, A., P. Gines, V. Arroyo, J. Camps, R.M. Perez-Ayuso, E. Quintero, J. Gaya, F. Rivera, and J. Rodes. 1986. Urinary excretion of 6-ketoprostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites: relationship to functional renal failure (hepatorenal syndrome). J. Hepatol. 3:111-117.
12. Moore, K., P.S. Ward, G.W. Taylor, and R. Williams. 1991. Systemic and renal production of thromboxane A2 and prostacyclin in decompensated liver disease and hepatorenal syndrome. Gastroenterology. 100:1069-1077.
13. Laffi, G., G. La Villa, M. Pinzani, G. Ciabattoni, P. Patrignani, M. Mannelli, F. Cominelli, and P. Gentilini. 1986. Altered renal and platelet arachidonic acid metabolism in cirrhosis. Gastroenterology. 90:274-282.
14. Wong, P.Y., R.C. Talamo, and G.H. Williams. 1977. Kallikrein-kinin and renin-angiotensin systems in functional renal failure of cirrhosis of the liver. Gastroenterology. 73:1114-1118.
15. Perez-Ayuso, R.M., V. Arroyo, J. Camps, A. Rimola, J. Costa, J. Gaya, F. Rivera, and J. Rodes. 1984. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics. Hepatology. 4:247-252.
16. Guarner, C., G. Soriano, A. Tomas, O. Bulbena, M.T. Novella, J. Balanzo, F. Vilardell, M. Mourelle, and S. Moncada. 1993. Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia. Hepatology. 18:1139-1143.
17. Boyer, T.D., P. Zia, and T.B. Reynolds. 1979. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease. Gastroenterology. 77:215-222.
18. Zipser, R.D., I. Kronborg, W. Rector, T. Reynolds, and G. Daskalopoulos. 1984. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome. Gastroenterology. 87:1228-1232.
19. McGiff, J.C. 1991. Cytochrome P-450 metabolism of arachidonic acid. Ann. Rev. Pharmacol. Toxicol. 31:339-369.
20. Carroll, M.A., M.P. Garcia, J.R. Falck, and J.C. McGiff. 1992. Cyclooxygenase dependency of the renovascular actions of cytochrome P450-derived arachidonate metabolites. J. Pharmacol. Exp. Ther. 260:104-109.
21. Escalante, B., W. Sessa, J.R. Falck, P. Yadagiri, and M.L. Schwartzman. 1989. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther. 248:229-232.
22. Takahashi, K., J. Capdevila, A. Karara, J.R. Falck, H.R. Jacobson, and K. Badr. 1990. Cytochrome P-450 arachidonate metabolites in rat kidney: characterization and hemodynamic responses. Am. J. Physiol. 258:F781-F789.
23. Ma, Y.H., D. Gebremedhin, M.L. Schwartzman, J.R. Falck, J.E. Clark, B.S. Masters, D.R. Harder, and R.J. Roman. 1993. 20-hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ. Res. 72:126-136.
24. Escalante, B., D. Erlij, J.R. Falck, and J.C. McGiff. 1991. Effect of cytochrome P-450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle. Science (Wash. DC). 251:799.
25. Escalante, B., D. Erlij, J.R. Falck, and J.C. McGiff. 1994. Cytochrome P450 arachidonate metabolites affect ion fluxes in rabbit medullary thick ascending limb. Am. J. Physiol. 266:C1775-C1782.
26. Omata, K., N.G. Abraham, and M. Laniado Schwartzman. 1992. Renal cytochrome P-450-arachidonic acid metabolism: localization and hormonal regulation in SHR. Am. J. Physiol. 262:F591-F599.
27. Carroll, M.A., A. Sala, C.E. Dunn, J.C. McGiff, and R.C. Murphy. 1991. Structural identification of cytochrome P450-dependent arachidonate metabolites formed by rabbit medullary thick ascending limb cells. J. Biol. Chem. 266: 12306-12312.
28. Zou, A.P., J.D. Imig, M. Kaldunski, P.R. Ortiz-de-Montellano, Z. Sui, and R.J. Roman. 1994. Inhibition of renal vascular 20-HETE production impairs autoregulation of renal blood flow. Am. J. Physiol. 266:F275-F282.
29. Zou, A.P., J.D. Imig, P.R. Ortiz-de-Montellano, Z. Sui, J.R. Falck, and R.J. Roman. 1994. Effect of P-450 ω-hydroxylase metabolites of arachidonic acid on tubuloglomerular feedback. Am. J. Physiol. 266:F934-F941.
30. Sacerdoti, D., B. Escalante, N.G. Abraham, J.C. McGiff, R.D. Levere, and M.L. Schwartzman. 1989. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science (Wash DC). 243:388-390.
31. Prakash, C., J.Y. Zhang, J.R. Falck, K. Chauhan, and I.A. Blair. 1992. 20-hydroxyeicosatetraenoic acid is excreted as a glucuronide conjugate in human urine. Biochem. Biophys. Res. Commun. 185:728-733.
32. Carroll, M.A., M. Balazy, P. Margiotta, D.D. Huang, J.R. Falck, and J.C. McGiff. 1996. Cytochrome P450-derived renal HETEs: biological profiles and differential stimulation by vasoactive peptides. Am. J. Physiol. 271:R863-R869.
33. Carroll, M.A., M. Balazy, D.-D. Huang, S. Rybalova, J.R. Falck, and J.C. McGiff, 1997. Cytochrome P450-derived renal HETEs: Storage and release. Kidney Int. 51:1696-1702.
34. Pugh, R.N.H., L.M. Murray-Lyon, J.L. Pawson, M.C. Pietroni, and R. Williams. 1973. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 60:646-664.
35. Pradelles, P., J. Grassi, and J. Maclouf. 1985. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 57:1170-1173.
36. 2 release. Hypertension (Dallas). 25:1238-1244.
37. Thomsen, K. 1984. The lithium clearance: a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron. 37: 217-223.
38. Falck, J.R., S. Lumin, I. Blair, E. Dishman, M.V. Martin, D.J. Waxman, F.P. Guengerich, and J.H. Capdevila. 1990. Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17-, and 18-hydroxyeicosatetraenoic acids. J. Biol. Chem. 265:10244-10249.
39. Sealey, J.E., G.D. James, and J.H. Laragh. 1995. Interpretation and guidelines for the use of plasma and urine aldosterone and plasma angiotensin II, angiotensinogen, prorenin, peripheral, and renal vein renin tests. In Hypertension. J.H. Laragh and B.M. Brenner, editors. Raven Press, Ltd., New York. 1953-1968.
40. Moore, K., J. Wendon, M. Frazer, J. Karani, R. Williams, and K. Badr. 1992. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N. Engl. J. Med. 327:1774-1778.
41. Oyekan, A., M. Balazy, and J.C. McGiff. 1997. Renal oxygenases: differential contribution to vasoconstriction induced by Endothelin-1 and Angiotensin II. Am. J. Physiol. 273:R293-R300.
42. Imig, J.D., A.P. Zou, D.E. Stec, D.R. Harder, J.R. Falck, and R.J. Roman. 1996. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270:R217-R227.
43. Harder, D.R., J. Narayanan, D. Gebremedhin, and R.J. Roman. 1996. Transduction of physical force by the vascular wall. Trends Cardiovasc. Med. 5: 7-14.
44. Bock, K.W., U.C. Clausbruch, R. Kaufmann, W. Lilienblum, F. Oesch, H. Pfeil, and K.L. Platt. 1980. Functional heterogenity of UDP-glucuronyltransferase in rat tissues. Biochem. Pharmacol. 29:495-500.
45. Yue, Q., I. Odar-Cederlof, J.O. Svensson, and J. Sawe. 1988. Glucuronidation of morphine in human kidney microsomes. Pharmacol. Toxicol. 63: 337-341.
46. Schwartzman, M.L., and J.C. McGiff.. 1995. Renal cytochrome P450. J. Lipid Mediators. 12:229-242.
47. Carroll, M.A., K.D. Croft, and J.C. McGiff. 1997. Angiotensin II (AII) stimulates release of cytochrome P450 (P450)-derived hydroxyeicosatetraenoic acids (HETEs) from renal microvessels. Microcirculation 4:189 (Abstract).
48. Hardwick, J.P. 1991. CYP4A subfamily: functional analysis by immunohistochemistry and in situ hybridization. In Methods in Enzymology. Michael R. Waterman and Eric F. Johnson, editors. Academic Press, Inc., San Diego, CA. 206, 273:283.
49. Roman, R.J., and A.P. Zou. 1993. Influence of the renal medullary circulation on the control of sodium excretion. Am. J. Physiol. 265:R963-R973.